Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.

AusPAR: Cladribine

Australian Public Assessment Report

AusPAR

Australian Public Assessment Report for Cladribine [PDF, 808.23 KB]

Australian Public Assessment Report for Cladribine [DOCX, 1.58 MB]

Attachment: Product Information: Cladribine [PDF, 274 KB]

Attachment: Product Information: Cladribine [DOCX, 123.53 KB]

Attachment: Extract from Clinical Evaluation Report: Cladribine [PDF, 6.56 MB]

Attachment: Extract from Clinical Evaluation Report: Cladribine [DOCX, 18.85 MB]

Device/Product Name

Mavenclad

Active ingredients

Cladribine

AusPAR Date

25 June 2018

Published

16 July 2018

Submission Number

PM-2016-03923-1-1

Submission Type

Extension of indications

Decision

Approved

Product types

Prescription medicines